Biotechnology

Pharmaceuticals

Coronavirus

biotechnology|pharmaceuticals|coronavirus

"They're going to need to push this out through more retail points, more community points," Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina, and former FDA commissioner, told CNBC's "Squawk Box" about New Jersey's vaccine distribution plan. "They can't just open up big vaccination centers in giant stadiums and expect 70-year-old people to drive out and line up."